|
|
|
|
|
00000cam0a22000004ib4500 |
| 001 |
BY-NLB-br336294 |
| 005 |
20070615181637.1 |
| 010 |
# |
# |
$a 92-871-4437-0
$d 1000 r.
|
| 100 |
# |
# |
$a 20010529d2000 u y0rusy50 ca
|
| 101 |
0 |
# |
$a eng
|
| 102 |
# |
# |
$a fr
|
| 105 |
# |
# |
$a y d 000yy
|
| 109 |
# |
# |
$a ja
|
| 200 |
1 |
# |
$a The pharmacist at the crossroads of new health risks: an indispensable pertner for their management!
$e Seminar, Strasbourg, 20-22 October 1999
|
| 210 |
# |
# |
$a Strasbourg
$c Council of Europe Publ.
$d 2000
|
| 215 |
# |
# |
$d 30 см.
|
| 225 |
1 |
# |
$a Health protection of the consumer
|
| 461 |
# |
0 |
$1 50010
$a Health protection of the consumer.
|
| 606 |
0 |
# |
$3 BY-NLB-ar35697
$a ФАРМАЦЕВТЫ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar33534
$a ТЕРАПИЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar10847
$a ЗАЩИТА ПРАВ ПОТРЕБИТЕЛЕЙ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar42954
$a ПРОДАЖИ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar43490
$a ИНТЕРНЕТ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar52329
$a САМОЛЕЧЕНИЕ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar24047
$a ПОДДЕЛКА (юрид.)
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar35698
$a ФАРМАЦЭЎТЫ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar15874
$a ЛЕКАВЫЯ СРОДКІ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar33535
$a ТЭРАПІЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar10848
$a АБАРОНА ПРАВОЎ СПАЖЫЎЦОЎ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar42955
$a ПРОДАЖ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar43491
$a ІНТЭРНЭТ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar52330
$a САМАЛЯЧЭННЕ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar24048
$a ПАДРОБКА (юрыд.)
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar15873
$a ЛЕКАРСТВЕННЫЕ СРЕДСТВА
$2 DVNLB
|
| 675 |
# |
# |
$a 615.15(4)(063)
$v 3
$z rus
|
| 675 |
# |
# |
$a 366.438:661.12(4)(063)
$v 3
$z rus
|
| 686 |
# |
# |
$a 76.31.29
$2 rugasnti
|
| 686 |
# |
# |
$a 76.31.35
$2 rugasnti
|
| 710 |
0 |
2 |
$3 BY-NLB-ar170066
$a Council of Europe
|
| 801 |
# |
0 |
$a BY
$b BY-HM0000
$c 20010529
$g psbo
|
| 801 |
# |
1 |
$a BY
$b BY-HM0000
$c 20060315
$g psbo
|
